Name: 글로벌 시장 동향
SKU: MD2712
Availability: InStock

보고서 요약(국문)

수술 로봇 시장은 2021년 50억 5천만 달러 규모였으며, 2029년에는 11억 5천만 달러에 이를 것으로 예상됩니다. 예측 기간(2023~2030년) 동안 연평균 성장률(CAGR)은 11.52%입니다. 로봇 보조 수술(RAS)은 획기적인 의료 기술로, 최소 침습 수술 분야에서 높은 주목을 받고 있습니다.
외과의사들은 기존 수술 방식보다 더 높은 정확성, 제어력, 유연성을 바탕으로 고위험의 복잡한 수술을 수행하기 위해 RAS 장비를 선호하고 있습니다. 수술 로봇은 최소 침습적인 복강경(또는 키홀) 접근법을 기반으로 수술을 수행함으로써 침습적 수술과 관련된 여러 가지 한계를 극복했습니다.
DataM Intelligence의 수술 로봇 시장 연구 분석은 정량적 및 정성적 데이터를 포함하는 심층적인 시장 전망을 제공합니다. 또한 시장 세분화를 기반으로 글로벌 시장에 대한 전망과 예측을 제시합니다. 이 보고서는 미국, 캐나다, 브라질, 독일, 이탈리아, 스페인, 영국, 러시아, 유럽 국가, 아랍에미리트, 사우디아라비아, 남아프리카공화국, 일본, 중국, 인도, 한국, 호주 등 주요 국가를 포함한 전 세계 수술 로봇 시장의 규모, 성장률, 최신 동향, 기회 및 2029년까지의 전망을 제공합니다.
모든 지역 중 북미 지역은 예측 기간 동안 전 세계 시장에서 가장 큰 비중을 차지할 것으로 예상됩니다. 미국과 캐나다의 수술 로봇 시장이 가장 큰 비중을 차지할 것으로 전망됩니다. 유럽 수술 로봇 시장은 2023년부터 2030년까지 전 세계적으로 지속적인 성장을 보일 것으로 예상됩니다.
수술 로봇 시장 동향 및 추세
수술 로봇 시장은 회복 시간 단축, 입원 기간 단축, 수술 후 통증 감소 및 임상적 효능 향상과 같은 임상적 이점 덕분에 최소 침습 수술에 대한 수요 증가를 주도해 왔습니다. 만성 질환과 암 발병률 증가로 수술적 치료에 대한 임상적 수요가 늘어나면서 시장 성장이 촉진될 것입니다. 또한, 신제품 혁신, 신흥국의 의료비 지출 증가, 그리고 일부 국가의 유리한 의료비 상환 환경이 시장 성장을 더욱 가속화할 것입니다.
하지만 고가의 제품은 신흥 시장에서 제품의 시장 침투를 제한하는 주요 요인입니다. 예를 들어, 다빈치 수술 시스템의 가격은 50만 달러에서 250만 달러에 이릅니다. 따라서 특히 신흥국의 의료 시설은 이러한 장비를 구매할 여력이 부족합니다. 또한, 합병증 발생 위험과 제품 리콜 가능성 역시 수술 로봇 장비의 시장 침투를 저해하는 요소입니다.
수술 로봇 시장 세분화 분석
제품별로 전 세계 수술 로봇 시장은 로봇 수술 시스템, 수술 기구 및 액세서리, 로봇 수술 서비스의 세 가지 주요 부문으로 분류됩니다. 수술 기구 및 액세서리 부문이 시장의 50% 이상을 차지하며 가장 큰 비중을 차지하고 있습니다. 성장률 측면에서도 기기 및 액세서리 부문은 반복적인 수익 창출로 인해 높은 성장률을 보일 것으로 예상됩니다.
수술 로봇 시장 지역별 분석:
글로벌 수술 로봇 시장은 북미, 유럽, 아시아 태평양, 남미 및 기타 지역으로 구분됩니다. 북미는 제품 보급률이 높고, 외과의사와 환자 모두 로봇 기술을 수용하는 비율이 높으며, 선진 의료 인프라와 유리한 의료비 상환 환경으로 인해 시장에서 가장 큰 비중을 차지하고 있습니다. 아시아 태평양 지역은 의료 수준 향상과 특히 중국, 인도와 같은 국가에서 첨단 의료 장비에 대한 수요 증가로 인해 가장 높은 성장률을 보일 것으로 예상됩니다.
수술 로봇 기업 및 경쟁 환경:
수술 로봇 시장은 경쟁이 매우 치열하고 세분화되어 있습니다. 소수의 기업들이 시장의 상당 부분을 차지하고 있으며, 나머지는 여러 소규모 기업과 스타트업이 차지하고 있습니다. 시장의 거의 모든 주요 기업들은 대학과의 연구 협력 및 전략적 인수합병에 집중하고 있습니다. 예를 들어, 2022년 5월 3일, Auris Health Inc는 자사의 의료용 수술 로봇 시스템이 기관지 내시경 및 비뇨기과 시술 모두에 대해 FDA 510(K) 승인을 받았다고 발표했습니다.
2021년 12월 8일, Auris Health는 홍콩에서 로봇 보조 기관지 내시경 시술인 MONARCH를 시행했다고 발표했는데, 이는 미국 이외 지역에서 시행된 최초의 MONARCH 시술입니다. MONARCH는 생검을 통해 로봇 보조 기관지 내시경의 임상 안전성과 진단 정확도를 평가하도록 설계되었습니다.
2022년 4월 12일, Intuitive Surgical은 다빈치 수술 시스템을 사용하는 외과의를 위한 독자적인 플랫폼인 My intuitive 앱(MIA)을 출시했습니다.

보고서 요약(영어 원문)

Surgical Robotics Market was valued at USD 5050 million in 2021. It is forecasted to reach USD million by 2029, growing at a CAGR of 11.52% during the forecast period (2023-2030). Robot-assisted surgery (RAS) is a breakthrough medical technology and is gaining high traction for minimally invasive surgeries.
RAS equipment are being highly preferred by surgeons to perform high-risk complex surgical procedures with more accuracy, control, and flexibility compared to conventional surgical procedures. Surgical robots have overcome the multiple limitations related to invasive surgical procedures as it is based on a minimally invasive laparoscopic (or keyhole) approach to perform surgeries.
As per DataM Intelligence, Surgical Robotics Market study analysis offers an in-depth outlook on the market containing quantitative and qualitative data. It gives an outlook and forecast of the global market based on market segmentation. It also provides global Surgical Robotics Market size, and growth, along with the latest trends, opportunities, and forecast till 2029 for the global market with esteem to major countries such as the United States, Canada, Brazil, Germany, Italy, Spain, United Kingdom, Russia, European countries, United Arab Emirates, Saudi Arabia, South Africa, Japan, China, India, South Korea, Australia, and rest of the countries over the globe.
Among all regions, the North American region is expected to hold the largest share of the global market over the forecast period. Surgical Robotics Market in the United States and Canada produces the utmost share. Whereas the European Surgical Robotics Market is projected to continue its presence globally during the period of 2023-2030.
Surgical Robotics Market Dynamics and Trends
The market for surgical robotics has primarily driven the intensification of demand for minimally invasive surgeries due to clinical benefits such as reduced recovery time, hospital stay, and postoperative pain and clinical efficacy. The rising prevalence of chronic conditions and cancers will also boost the market growth as it in turn increases the clinical need for surgical interventions. In addition, new product innovations, rising healthcare expenditures in emerging countries, and a favorable reimbursement landscape in selected countries will further boost the market growth.
Premium product costs will majorly limit high product entrenchment in emerging markets. For instance, the cost of the da Vinci surgical system ranges from USD 0.5 million to USD 2.5 million. Thus, healthcare facilities in especially in emerging have low affordability scope for these devices. In addition, the risk of associated complications and product recalls are other restraints for surgical robotic equipment
Surgical Robotics Market Segmentation Analysis
By product, the global surgical robotics market is categorized into three broad product segments – Robotic surgery systems, Instruments and accessories, and Robotic surgery services. The instruments and accessories segment occupied the dominant share of more than 50% of the market. In terms of growth rate too, the instruments and accessories segment will witness high growth owing to the generation of recurring revenues.
Surgical Robotics Market Geographical Presentation:
The global surgical robotics market is segmented into North America, Europe, Asia Pacific, South America, and ROW. North America accounts for the dominant market share owing to the highest product entrenchment, high acceptance of robotics by surgeons as well as patients, advanced health care infrastructure, and favorable reimbursement landscape. The Asia Pacific is expected to witness the highest growth rate due to rising healthcare standards and an increase in demand for advanced medical equipment especially in countries such as China and India.
Surgical Robotics Companies and Competitive Landscape:
The market for surgical robotics is highly competitive and fragmented. Limited companies account for a major share of the market and the remaining minor share is occupied by several and small companies and start-ups. Almost all the top players in the market are focusing on the formation of research partnerships with universities and also strategic acquisitions. For instance, on 3rd May 2022, Auris Health Inc announced that its health surgical robot systems received 510(K) clearances from FDA for both bronchoscopy and urological procedures.
On 8th December 2021, Auris health announced that MONARCH is a robotic-assisted bronchoscopy procedure used in Hong Kong, marking this the first monarch procedure to take place outside of the United States. The Monarch is designed to evaluate the robotic-assisted bronchoscopy's clinical safety and diagnostic accuracy with biopsy.
On 12th April 2022, Intuitive Surgical launched its My intuitive app (MIA), a unique platform for surgeons using da Vinci surgical systems.

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition
2.1. Assumptions and Abbreviations
3. Executive Summary
3.1. Market Snippet by Product Type
3.2. Market Snippet by Indication
3.3. Market Snippet by Region
4. Market-Dynamics
4.1. Market Impacting Factors
4.2. Drivers
4.3. Restraints
5. Industry Force
5.1. Porter's Five Forces Analysis
6. By Product Type
6.1. Introduction
6.1.1. Market Size Analysis, US$ Million, 2018-2027 and Y-o-Y Growth Analysis (%), 2019-2027, By Product Type
6.1.2. Market Attractiveness Index, By Product Type
6.2. Robotic Surgery Systems*
6.2.1. Introduction
6.2.2. Market Size Analysis, USD Million, 2017-2026 and Y-o-Y Growth Analysis (%), 2018-2026
6.3. Instruments and Accessories
6.4. Robotic Surgery Services
7. By Indication
7.1. Introduction
7.1.1. Market Size Analysis, US$ Million, 2018-2027 and Y-o-Y Growth Analysis (%), 2019-2027, By Indication
7.1.2. Market Attractiveness Index, By Indication
7.2. General Surgery *
7.2.1. Introduction
7.2.2. Market Size Analysis, USD Million, 2017-2026 and Y-o-Y Growth Analysis (%), 2018-2026
7.3. Orthopedic
7.4. Neurosurgery
7.5. Cardiovascular
7.6. Gynecology
7.7. Radiology
7.8. Others
8. By Region
8.1. Introduction
8.1.1. Market Size Analysis, US$ Million, 2018-2027 and Y-o-Y Growth Analysis (%), 2019-2027,By Region
8.1.2. Market Attractiveness Index, By Region
8.2. North America
8.2.1. Introduction
8.2.2. Key Region-Specific Dynamics
8.2.3. Market Size Analysis, US$ Million, 2018-2027 and Y-o-Y Growth Analysis (%), 2019-2027, by Product Type
8.2.4. Market Size Analysis, US$ Million, 2018-2027 and Y-o-Y Growth Analysis (%), 2019-2027, by Indication
8.2.5. Market Size Analysis, US$ Million, 2018-2027 and Y-o-Y Growth Analysis (%), 2019-2027, by Country
8.2.5.1. U.S.
8.2.5.2. Canada
8.2.5.3. Mexico
8.3. Europe
8.3.1. Introduction
8.3.2. Key Region-Specific Dynamics
8.3.3. Market Size Analysis, US$ Million, 2018-2027 and Y-o-Y Growth Analysis (%), 2019-2027, by Product Type
8.3.4. Market Size Analysis, US$ Million, 2018-2027 and Y-o-Y Growth Analysis (%), 2019-2027, by Indication
8.3.5. Market Size Analysis, US$ Million, 2018-2027 and Y-o-Y Growth Analysis (%), 2019-2027, by Country
8.3.5.1. Germany
8.3.5.2. U.K.
8.3.5.3. France
8.3.5.4. Russia
8.3.5.5. Rest of Europe
8.4. South America
8.4.1. Introduction
8.4.2. Key Region-Specific Dynamics
8.4.3. Market Size Analysis, US$ Million, 2018-2027 and Y-o-Y Growth Analysis (%), 2019-2027, by Product Type
8.4.4. Market Size Analysis, US$ Million, 2018-2027 and Y-o-Y Growth Analysis (%), 2019-2027, by Indication
8.4.5. Market Size Analysis, US$ Million, 2018-2027 and Y-o-Y Growth Analysis (%), 2019-2027, by Country
8.4.5.1. Brazil
8.4.5.2. Argentina
8.4.5.3. Rest of South America
8.5. Asia-Pacific
8.5.1. Introduction
8.5.2. Key Region-Specific Dynamics
8.5.3. Market Size Analysis, US$ Million, 2018-2027 and Y-o-Y Growth Analysis (%), 2019-2027, by Product Type
8.5.4. Market Size Analysis, US$ Million, 2018-2027 and Y-o-Y Growth Analysis (%), 2019-2027, by Indication
8.5.5. Market Size Analysis, US$ Million, 2018-2027 and Y-o-Y Growth Analysis (%), 2019-2027, by Country
8.5.5.1. China
8.5.5.2. India
8.5.5.3. Japan
8.5.5.4. Australia
8.5.5.5. Rest of Asia-Pacific
8.6. Middle East and Africa
8.6.1. Introduction
8.6.2. Key Region-Specific Dynamics
8.6.3. Market Size Analysis, US$ Million, 2018-2027 and Y-o-Y Growth Analysis (%), 2019-2027, by Product Type
8.6.4. Market Size Analysis, US$ Million, 2018-2027 and Y-o-Y Growth Analysis (%), 2019-2027, by Indication
9. Competitive Landscape
9.1. Competitor Analysis
9.2. Market Positioning/Share Analysis
9.3. Mergers and Acquisitions Analysis
9.4. Key Strategies adopted by Manufacturers
10. Company Profiles
10.1. Auris Surgical Robotics. *
10.1.1. Company Overview
10.1.2. Product Portfolio and Description
10.1.3. Key Highlights
10.1.4. Financial Overview
10.2. Neurosurgery
10.3. Intuitive Surgical
10.4. Stryker Corporation/MAKO
10.5. Medtech Surgical
10.6. Hansen Medical
10.7. Mazor Robotics
10.8. THINK Surgical
10.9. Medrobotics Corporation
10.10. TransEnterix
10.11. Varian Medical Systems
10.12. Titan Medical
10.13. Accuray (*List is not exhaustive)
11. DataM Intelligence
11.1. Appendix
11.2. About Us and Services
11.3. Contact Us

언급된 주요 기업들

Auris Surgical Robotics., Neurosurgery, Intuitive Surgical, Stryker Corporation/MAKO, Medtech Surgical, Hansen Medical, Mazor Robotics, THINK Surgical, Medrobotics Corporation, TransEnterix, Varian Medical Systems, Titan Medical

표 목록 (Tables)

List of Tables

Table 1 Global Surgical Robots Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)

Table 2 Global Surgical Robots Market Value, By Indication, 2025, 2029 & 2033 (US$ Billion)

Table 3 Global Surgical Robots Market Value, By Patient Age Group, 2025, 2029 & 2033 (US$ Billion)

Table 4 Global Surgical Robots Market Value, By End User, 2025, 2029 & 2033 (US$ Billion)

Table 5 Global Surgical Robots Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)

Table 6 Global Surgical Robots Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)

Table 7 Global Surgical Robots Market Value, By Product Type, 2024-2033 (US$ Billion)

Table 8 Global Surgical Robots Market Value, By Indication, 2025, 2029 & 2033 (US$ Billion)

Table 9 Global Surgical Robots Market Value, By Indication, 2024-2033 (US$ Billion)

Table 10 Global Surgical Robots Market Value, By Patient Age Group, 2025, 2029 & 2033 (US$ Billion)

Table 11 Global Surgical Robots Market Value, By Patient Age Group, 2024-2033 (US$ Billion)

Table 12 Global Surgical Robots Market Value, By End User, 2025, 2029 & 2033 (US$ Billion)

Table 13 Global Surgical Robots Market Value, By End User, 2024-2033 (US$ Billion)

Table 14 Global Surgical Robots Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)

Table 15 Global Surgical Robots Market Value, By Region, 2024-2033 (US$ Billion)

Table 16 North America Surgical Robots Market Value, By Product Type, 2024-2033 (US$ Billion)

Table 17 North America Surgical Robots Market Value, By Indication, 2024-2033 (US$ Billion)

Table 18 North America Surgical Robots Market Value, By Patient Age Group, 2024-2033 (US$ Billion)

Table 19 North America Surgical Robots Market Value, By End User, 2024-2033 (US$ Billion)

Table 20 North America Surgical Robots Market Value, By Country, 2024-2033 (US$ Billion)

Table 21 Asia-Pacific Surgical Robots Market Value, By Product Type, 2024-2033 (US$ Billion)

Table 22 Asia-Pacific Surgical Robots Market Value, By Indication, 2024-2033 (US$ Billion)

Table 23 Asia-Pacific Surgical Robots Market Value, By Patient Age Group, 2024-2033 (US$ Billion)

Table 24 Asia-Pacific Surgical Robots Market Value, By End User, 2024-2033 (US$ Billion)

Table 25 Asia-Pacific Surgical Robots Market Value, By Country, 2024-2033 (US$ Billion)

Table 26 Europe Surgical Robots Market Value, By Product Type, 2024-2033 (US$ Billion)

Table 27 Europe Surgical Robots Market Value, By Indication, 2024-2033 (US$ Billion)

Table 28 Europe Surgical Robots Market Value, By Patient Age Group, 2024-2033 (US$ Billion)

Table 29 Europe Surgical Robots Market Value, By End User, 2024-2033 (US$ Billion)

Table 30 Europe Surgical Robots Market Value, By Country, 2024-2033 (US$ Billion)

Table 31 South America Surgical Robots Market Value, By Product Type, 2024-2033 (US$ Billion)

Table 32 South America Surgical Robots Market Value, By Indication, 2024-2033 (US$ Billion)

Table 33 South America Surgical Robots Market Value, By Patient Age Group, 2024-2033 (US$ Billion)

Table 34 South America Surgical Robots Market Value, By End User, 2024-2033 (US$ Billion)

Table 35 South America Surgical Robots Market Value, By Country, 2024-2033 (US$ Billion)

Table 36 Middle East and Africa Surgical Robots Market Value, By Product Type, 2024-2033 (US$ Billion)

Table 37 Middle East and Africa Surgical Robots Market Value, By Indication, 2024-2033 (US$ Billion)

Table 38 Middle East and Africa Surgical Robots Market Value, By Patient Age Group, 2024-2033 (US$ Billion)

Table 39 Middle East and Africa Surgical Robots Market Value, By End User, 2024-2033 (US$ Billion)

Table 40 Middle East and Africa Surgical Robots Market Value, By Country, 2024-2033 (US$ Billion)

Table 41 F Hoffmann-La Roche Ltd: Overview

Table 42 F Hoffmann-La Roche Ltd: Product Portfolio

Table 43 F Hoffmann-La Roche Ltd: Key Developments

Table 44 Novartis AG: Overview

Table 45 Novartis AG: Product Portfolio

Table 46 Novartis AG: Key Developments

Table 47 Dr. Reddy's Laboratories Ltd: Overview

Table 48 Dr. Reddy's Laboratories Ltd: Product Portfolio

Table 49 Dr. Reddy's Laboratories Ltd: Key Developments

Table 50 Glenmark Pharmaceuticals: Overview

Table 51 Glenmark Pharmaceuticals: Product Portfolio

Table 52 Glenmark Pharmaceuticals: Key Developments

Table 53 Almirall: Overview

Table 54 Almirall: Product Portfolio

Table 55 Almirall: Key Developments

Table 56 Bayer AG: Overview

Table 57 Bayer AG: Product Portfolio

Table 58 Bayer AG: Key Developments

Table 59 Sanofi: Overview

Table 60 Sanofi: Product Portfolio

Table 61 Sanofi: Key Developments

Table 62 Asahikasei Pharm: Overview

Table 63 Asahikasei Pharm: Product Portfolio

Table 64 Asahikasei Pharm: Key Developments

Table 65 Organon Global Inc: Overview

Table 66 Organon Global Inc: Product Portfolio

Table 67 Organon Global Inc: Key Developments

Table 68 Teva Pharmaceuticals: Overview

Table 69 Teva Pharmaceuticals: Product Portfolio

Table 70 Teva Pharmaceuticals: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Surgical Robots Market Value, 2024-2033 (US$ Billion)

Figure 2 Global Surgical Robots Market Share, By Product Type, 2024 & 2033 (%)

Figure 3 Global Surgical Robots Market Share, By Indication, 2024 & 2033 (%)

Figure 4 Global Surgical Robots Market Share, By Patient Age Group, 2024 & 2033 (%)

Figure 5 Global Surgical Robots Market Share, By End User, 2024 & 2033 (%)

Figure 6 Global Surgical Robots Market Share, By Region, 2024 & 2033 (%)

Figure 7 Global Surgical Robots Market Y-o-Y Growth, By Product Type, 2025-2033 (%)

Figure 8 Antihistamines Surgical Robots Market Value, 2024-2033 (US$ Billion)

Figure 9 Corticosteroids Surgical Robots Market Value, 2024-2033 (US$ Billion)

Figure 10 Cyclosporine Surgical Robots Market Value, 2024-2033 (US$ Billion)

Figure 11 Leukotriene Receptor Antagonists Surgical Robots Market Value, 2024-2033 (US$ Billion)

Figure 12 Omalizumab (Xolair) Surgical Robots Market Value, 2024-2033 (US$ Billion)

Figure 13 Hydroxychloroquine (Plaquenil) Surgical Robots Market Value, 2024-2033 (US$ Billion)

Figure 14 Others Surgical Robots Market Value, 2024-2033 (US$ Billion)

Figure 15 Global Surgical Robots Market Y-o-Y Growth, By Indication, 2025-2033 (%)

Figure 16 Oral Indication in Global Surgical Robots Market Value, 2024-2033 (US$ Billion)

Figure 17 Topical Indication in Global Surgical Robots Market Value, 2024-2033 (US$ Billion)

Figure 18 Intravenous Indication in Global Surgical Robots Market Value, 2024-2033 (US$ Billion)

Figure 19 Others Indication in Global Surgical Robots Market Value, 2024-2033 (US$ Billion)

Figure 20 Global Surgical Robots Market Y-o-Y Growth, By Patient Age Group, 2025-2033 (%)

Figure 21 Pediatric Patient Age Group in Global Surgical Robots Market Value, 2024-2033 (US$ Billion)

Figure 22 Adult Patient Age Group in Global Surgical Robots Market Value, 2024-2033 (US$ Billion)

Figure 23 Geriatric Patient Age Group in Global Surgical Robots Market Value, 2024-2033 (US$ Billion)

Figure 24 Global Surgical Robots Market Y-o-Y Growth, By End User, 2025-2033 (%)

Figure 25 Hospital Pharmacies End User in Global Surgical Robots Market Value, 2024-2033 (US$ Billion)

Figure 26 Retail Pharmacies End User in Global Surgical Robots Market Value, 2024-2033 (US$ Billion)

Figure 27 Online Pharmacies End User in Global Surgical Robots Market Value, 2024-2033 (US$ Billion)

Figure 28 Global Surgical Robots Market Y-o-Y Growth, By Region, 2025-2033 (%)

Figure 29 North America Surgical Robots Market Value, 2024-2033 (US$ Billion)

Figure 30 North America Surgical Robots Market Share, By Product Type, 2024 & 2033 (%)

Figure 31 North America Surgical Robots Market Share, By Indication, 2024 & 2033 (%)

Figure 32 North America Surgical Robots Market Share, By Patient Age Group, 2024 & 2033 (%)

Figure 33 North America Surgical Robots Market Share, By End User, 2024 & 2033 (%)

Figure 34 North America Surgical Robots Market Share, By Country, 2024 & 2033 (%)

Figure 35 Asia-Pacific Surgical Robots Market Value, 2024-2033 (US$ Billion)

Figure 36 Asia-Pacific Surgical Robots Market Share, By Product Type, 2024 & 2033 (%)

Figure 37 Asia-Pacific Surgical Robots Market Share, By Indication, 2024 & 2033 (%)

Figure 38 Asia-Pacific Surgical Robots Market Share, By Patient Age Group, 2024 & 2033 (%)

Figure 39 Asia-Pacific Surgical Robots Market Share, By End User, 2024 & 2033 (%)

Figure 40 Asia-Pacific Surgical Robots Market Share, By Country, 2024 & 2033 (%)

Figure 41 Europe Surgical Robots Market Value, 2024-2033 (US$ Billion)

Figure 42 Europe Surgical Robots Market Share, By Product Type, 2024 & 2033 (%)

Figure 43 Europe Surgical Robots Market Share, By Indication, 2024 & 2033 (%)

Figure 44 Europe Surgical Robots Market Share, By Patient Age Group, 2024 & 2033 (%)

Figure 45 Europe Surgical Robots Market Share, By End User, 2024 & 2033 (%)

Figure 46 Europe Surgical Robots Market Share, By Country, 2024 & 2033 (%)

Figure 47 South America Surgical Robots Market Value, 2024-2033 (US$ Billion)

Figure 48 South America Surgical Robots Market Share, By Product Type, 2024 & 2033 (%)

Figure 49 South America Surgical Robots Market Share, By Indication, 2024 & 2033 (%)

Figure 50 South America Surgical Robots Market Share, By Patient Age Group, 2024 & 2033 (%)

Figure 51 South America Surgical Robots Market Share, By End User, 2024 & 2033 (%)

Figure 52 South America Surgical Robots Market Share, By Country, 2024 & 2033 (%)

Figure 53 Middle East and Africa Surgical Robots Market Value, 2024-2033 (US$ Billion)

Figure 54 Middle East and Africa Surgical Robots Market Share, By Product Type, 2024 & 2033 (%)

Figure 55 Middle East and Africa Surgical Robots Market Share, By Indication, 2024 & 2033 (%)

Figure 56 Middle East and Africa Surgical Robots Market Share, By Patient Age Group, 2024 & 2033 (%)

Figure 57 Middle East and Africa Surgical Robots Market Share, By End User, 2024 & 2033 (%)

Figure 58 F Hoffmann-La Roche Ltd: Financials

Figure 59 Novartis AG: Financials

Figure 60 Dr. Reddy's Laboratories Ltd: Financials

Figure 61 Glenmark Pharmaceuticals: Financials

Figure 62 Almirall: Financials

Figure 63 Bayer AG: Financials

Figure 64 Sanofi: Financials

Figure 65 Asahikasei Pharm: Financials

Figure 66 Organon Global Inc: Financials

Figure 67 Teva Pharmaceuticals: Financials